Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Humanised monoclonal antibody against CD38

EU orphan designation number: EU/3/14/1268   
Active ingredient: Humanised monoclonal antibody against CD38
Indication: Treatment of plasma cell myeloma
Sponsor: Sanofi-Aventis groupe
54 rue La Boétie, 75008 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
2/05/2014 Orphan designation EMA/OD/198/13 (2014)2974 of 29/04/2014